LiMM Therapeutics
Latest round
- Seed
Last raised
- Dec 2020
Total raised
- $6.1M
Investors
- 3
About LiMM Therapeutics
a. LiMM Therapeutics operates as a biotechnology company that focuses on developing therapeutic agents and drugs to combat infections or regulate immune reactions. The company develops solutions by decoding the neuroimmune crosstalk and offering NRILs (Neuronal Reprogrammers of Innate Lymphocytes) to combat inflammatory, infectious, and metabolic diseases. LiMM Therapeutics uncovers the intricate dialogue between neural and immune cells, enhancing immunology. The firm manipulates ILC and neuronal regulation, unveiling new therapeutic pathways for diverse diseases, including oncology.
Who invested in LiMM Therapeutics
3 investors across 1 round
See all investors in LiMM Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 21, 2020
Amount
$6.1M
Investors
Questions about LiMM Therapeutics
Who invested in LiMM Therapeutics?
LiMM Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LiMM Therapeutics raised?
LiMM Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did LiMM Therapeutics last raise money?
LiMM Therapeutics's most recent round on record is a Seed, in Dec 2020.
What does LiMM Therapeutics do?
LiMM Therapeutics is a biotechnology company.
Where is LiMM Therapeutics headquartered?
LiMM Therapeutics is headquartered in Paris, France.
Which VCs invest in companies like LiMM Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at LiMM Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like LiMM Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.